|
|
Recent Longevity News for the seven days ending
4/1/09. You should consult your doctor if you are taking any medications.
Vitamin K and prostate cancer – study supports benefits - Nutra USA, 3/31/09
- "increased intakes of
vitamin K2, but not K1, were associated with a 35 per cent reduction in
prostate cancer risk. The potential benefits of
K2 were more pronounced for advanced prostate cancer ... A higher ratio of
undercarboxylated osteocalcin (ucOC) to intact total osteocalcin (iOC) is
indicative of poorer vitamin K status ... of ucOC and iOC were analysed from
serum samples, and every 0.1 increment in the ratio was associated with a 38 per
cent increase in advanced-stage prostate cancer, and a 21 per cent increase in
high-grade prostate cancer" - [Abstract]
- See
vitamin K at Amazon.com.
Tocotrienol build-up in tumours ‘critical’ for anti-cancer benefits: Study -
Nutra USA, 3/31/09 - "the effects of
gamma- and delta-tocotrienol on mouse
cancer cells ... the diet supplemented with 0.1
per cent gamma-tocotrienol or 0.1 per cent delta-tocotrienol for four weeks ...
In conclusion, our results suggested that accumulation is critical for the
anti-tumour activity of tocotrienols" - [Abstract]
- See
Jarrow FamilE (contains all eight members of the vitamin E family, includes
Tocomin) at Amazon.com.
Note: If gamma-tocotrienol is critical for preventing cancer and alpha
vitamin E (the form found nearly always in supplements) reduces the gamma, it
seems like alpha vitamin E would increase cancer risks. See:
-
The
response of gamma vitamin E to varying dosages of alpha vitamin E plus
vitamin C - Metabolism. 2009 Apr;58(4):469-78 -
"at every dose of alpha vitamin E, gamma vitamin E concentration was
significantly suppressed"
-
Effect of oral supplementation with D-alpha-tocopherol on the vitamin E
content of human low density lipoproteins and resistance to oxidation -
J Lipid Res. 1991 Aug;32(8):1325-32 -
"gamma-Tocopherol significantly decreased in plasma
and LDL during vitamin E (alpha-tocopherol) supplementation"
Nonvertebral Fracture Prevention With Vitamin D May Be Dose-Dependent -
Medscape, 3/31/09 - "A dose-response relationship
between vitamin D and fracture reduction is
supported by epidemiologic data showing a significant positive trend between
serum 25-hydroxyvitamin D concentrations and hip
bone density and lower extremity strength"
New
Approach Discovered To Lowering Triglycerides - Science Daily, 3/30/09 -
"In the lab animals, supplements of
lipoic acid lowered
triglyceride levels up to 60 percent ...
supplements of lipoic acid appeared to affect triglyceride levels through two
pathways. After eating, lipoic acid supplementation increased the rate of
disappearance of triglycerides in the bloodstream. And supplements also reduced
the genetic expression of enzymes in the liver that synthesize triglycerides ...
Lipoic acid supplements have in various studies been shown to be an appetite
suppressant ... The amount of lipoic acid supplementation used in these
laboratory experiments would equate to about two grams per day for a 150-pound
person" - See
alpha lipoic acid at Amazon.com.
Early soy intake may slash breast cancer risk later in life - Nutra USA,
3/30/09 - "By comparing the highest and lowest
soy intake values for soy-based foods such as tofu,
miso and natto, Korde and co-workers calculated that women with the highest soy
intake during childhood (ages 5 to 11) had a 58 per cent lower risk of
breast cancer as adults as the women with the
lowest soy intake as children" - [Abstract]
Late Bedtimes Linked to Heart Disease - WebMD, 3/30/09 -
"The fewer hours a man slept
each night, the higher his BMI,
blood pressure, and
triglyceride levels"
Caffeine
Reduces Pain During Exercise, Study Shows - Science Daily, 3/30/09 -
"What's interesting ... is that when we found that
caffeine tolerance doesn't matter ... caffeine
reduces pain reliably, consistently during
cycling, across different intensities, across
different people, different characteristics"
High Dietary Fibre Intake Associated With Decreased Inflammation in Chronic and
Non-Chronic Kidney Disease Patients - Doctor's Guide, 3/30/09 -
"when compared with patients in the high
dietary fibre intake group, those in the low
intake group had significantly increased odds of inflammation in both the
CKD and non-CKD subgroups ... In the low
fibre intake group, CKD patients showed 51% inflammation versus 37% in the high
intake group (P < .05). The non-CKD population showed 29% inflammation with low
fibre intake versus 20% with high intake"
Study: Drinking Too-Hot Tea May Raise Esophageal Cancer Risk - WebMD,
3/26/09 - "hot tea
drinkers were twice as likely as warm or lukewarm tea drinkers to have
esophageal cancer"
Carotenoids linked to fewer hip fractures - Nutra USA, 3/26/09 -
"higher lycopene
intake was associated with a lower risk of
hip fracture, and non-vertebral fracture ... a weak but statistically
un-significant protective trend was recorded total beta-carotene, but only for
hip fractures ... No protective effects were observed for the other carotenoids"
- [Abstract] - See
lycopene at Amazon.com.
Daily
Consumption Of Cannabis Predisposes To Appearance Of Psychosis And
Schizophrenia, Study Finds - Science Daily, 3/25/09 -
"66% of the patients with psychosis who participated in
the study and had a normal neurodevelopment admitted to have consumed
cannabis daily or almost every day, whereas
43% of the participants with markers of an abnormal neurodevelopment (those
already indicated: bad previous social and academic behaviour, a family history
and a "clumsier" attitude when they carry out tasks of motor coordination and
complex motor acts) were drug users too"
New
Anti-cancer Drug: 200 Times More Active In Killing Tumor Cells - Science
Daily, 3/25/09 - "In humans, compounds like BPH-715 and
zoledronate have an added benefit in fighting cancer: They spur the
proliferation of immune cells called gamma delta T-cells, which aid in killing
tumor cells ... The new drugs are about 200 times more effective than the drugs
used in recent clinical trials at killing tumor cells and in activating gamma
delta T-cells to kill tumor cells ... They also prevent tumor progression in
mice much better than do existing bisphosphonate molecules" - Note:
I sounds like hope with terminal cancer, something I was looking for when they
inaccurately told me I had terminal neck
cancer.
ALA-DHA conversion negligible, say fatty acids experts - Nutra USA, 3/25/09
- "Alpha-linolenic acid, (ALA) does not convert to
docosahexaenoic acid (DHA) at levels that confer any physiological benefit ...
Each type of omega-3 has distinct nutritional functions. Nevertheless,
seafood/algal omega-3s – also known as long-chain
omega-3s – are more potent than terrestrial plant
sources of omega-3s and boast certain critical functions that terrestrial
plant-based omega-3s simply cannot perform"
Abstracts from this week's
Doctor's Guide Nutrition/Dietetics
plus abstracts from my RSS feeds (Click here
for the journals, the PubMed ones at the top):
Is Lowering
Phosphate Exposure The Key To Preventing Arterial Stiffening With Age? -
Heart. 2009 Mar 24 - "Diets in affluent populations are
high in phosphate because of increased
consumption of animal protein and the use of phosphate containing preservatives.
We suggest that the consumption of a phosphate rich diet, exacerbated by the
high prevalence of chronic kidney disease found in ageing populations,
accelerates the development of arteriosclerosis. We hypothesise that reducing
phosphate intake will attenuate the progression of arterial stiffness with major
beneficial effects upon cardiovascular mortality and morbidity"
Dietary
carotenoids and the risk of invasive breast cancer - Int J Cancer. 2009 Feb
3 - "An inverse association observed among premenopausal
women was for high levels of vitamin A (OR: 0.82, 95% CI: 0.68-0.98, p for trend
= 0.01), beta-carotene (OR: 0.81, 95% CI 0.68-0.98, p for trend = 0.009),
alpha-carotene (OR: 0.82, 95% CI: 0.68-0.98, p for trend = 0.07) and
lutein/zeaxanthin (OR: 0.83, 95% CI 0.68-0.99, p for trend = 0.02). An inverse
association was not observed among postmenopausal women. Among premenopausal
women who reported ever smoking, these results were stronger than among never
smokers, although tests for interaction were not statistically significant.
Results from this study are comparable to previous prospective studies, and
suggest that a high consumption of carotenoids
may reduce the risk of premenopausal but not postmenopausal
breast cancer, particularly among smokers" - See
Jarrow Formulas, CarotenALL at Amazon.com.
Specific accumulation of gamma- and delta-tocotrienols in tumor and their
antitumor effect in vivo - J Nutr Biochem. 2008 Sep 26 -
"In C3H/HeN mice implanted with MH134, it was found that
gamma-T3 and delta-T3 feeding significantly
delayed tumor growth ... Intriguingly, we found
that T3 was detected in tumor, but not in normal tissues. These results, to our
knowledge, are the first demonstration of specific accumulation of gamma-T3 and
delta-T3 in tumors and suggest that T3 accumulation is critical for the
antitumor activities of T3" - See
Jarrow FamilE (contains all eight members of the vitamin E family, includes
Tocomin) at Amazon.com.
Childhood Soy Intake and Breast Cancer Risk in Asian American Women - Cancer
Epidemiol Biomarkers Prev. 2009 Mar 24 - "Comparing
highest with lowest tertiles, the multivariate relative risks (95% confidence
interval) for childhood, adolescent, and adult soy intake were 0.40 (0.18-0.83;
Ptrend = 0.03), 0.80 (0.59-1.08; Ptrend = 0.12), and 0.76 (0.56-1.02; Ptrend =
0.04), respectively"
Acute
Effects Of Decaffeinated Coffee And The Major Coffee Components Chlorogenic Acid
And Trigonelline On Glucose Tolerance - Diabetes Care. 2009 Mar 26 -
"Coffee consumption has
been associated with a lower risk of type 2 diabetes. We evaluated the acute
effects of decaffeinated coffee and the major coffee components chlorogenic acid
and trigonelline on glucose tolerance ... Randomized cross-over trial of the
effects of 12 g decaffeinated coffee, 1 g chlorogenic acid, 500 mg trigonelline,
and placebo (1 g mannitol) on glucose and insulin concentrations during a 2-hour
oral glucose tolerance test (OGTT) in fifteen overweight men ... Chlorogenic
acid and trigonelline ingestion significantly reduced glucose (-0.7 mmol/L
p=0.007 and -0.5 mmol/L p=0.024 respectively) and insulin (-73 pmol/L p=0.038
and -117 pmol/L p=0.007 respectively) concentrations 15 minutes following an
OGTT as compared with placebo. None of the treatments affected insulin and
glucose area under the curve values during the OGTT as compared with placebo ...
Chlorogenic acid and trigonelline reduced early glucose and insulin responses
during an OGTT"
The relation
of {alpha}-linolenic acid to the risk of prostate cancer: a systematic review
and meta-analysis - Am J Clin Nutr. 2009 Mar 25 -
"High ALA intakes or high blood and adipose tissue concentrations of ALA may be
associated with a small increased risk of prostate cancer" - Note: I've
never been a fan of ALA (medium-chain n-3 polyunsaturated fatty acids such as
flaxseed oil) over fish oil (long-chain n-3 polyunsaturated fatty acids) but I
thought that was the only reason people took it and now even that's seems to be
proven wrong.
Protective Effect of Total Carotenoid and Lycopene Intake on the Risk of Hip
Fracture: A 17-Year Follow-Up From the Framingham Osteoporosis Study - J
Bone Miner Res. 2009 Jan 12 - "Subjects with higher
lycopene intake had lower risk of
hip fracture (P trend=0.01), and
non-vertebral fracture (P trend=0.02). A weak protective trend was observed for
total beta-carotene for hip fracture alone but associations did not reach
statistical significance (P trend=0.10). No significant associations were
observed with alpha-carotene, beta-cryptoxanthin or lutein plus zeaxanthin.
These results suggest a protective role of several carotenoids for bone health
in older adults" - See
lycopene at Amazon.com.
Total and
Cancer Mortality After Supplementation With Vitamins and Minerals: Follow-up of
the Linxian General Population Nutrition Intervention Trial - J Natl Cancer
Inst. 2009 Mar 24 - "Treatment with "factor D," a
combination of 50 mug selenium, 30 mg vitamin E, and 15 mg beta-carotene, led to
decreased mortality from all causes, cancer
overall, and gastric cancer ... Participants who received factor D had lower
overall mortality (HR = 0.95, 95% CI = 0.91 to 0.99; P = .009; reduction in
cumulative mortality from 33.62% to 32.19%) and gastric cancer mortality (HR =
0.89, 95% CI = 0.79 to 1.00; P = .043; reduction in cumulative gastric cancer
mortality from 4.28% to 3.84%) than subjects who did not receive factor D.
Reductions were mostly attributable to benefits to subjects younger than 55
years. Esophageal cancer deaths between those who did and did not receive factor
D were not different overall; however, decreased 17% among participants younger
than 55 (HR = 0.83, 95% CI = 0.71 to 0.98; P = .025) but increased 14% among
those aged 55 years or older (HR = 1.14, 95% CI = 1.00 to 1.30; P = .47)"
Low serum
levels of sex-steroids are associated with disease characteristics in primary
Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the
concentrations - J Clin Endocrinol Metab. 2009 Mar 24 -
"Dry mouth symptoms decreased during
DHEA therapy ... Disease manifestations in primary
Sjogren's syndrome were associated with low sex hormone levels, dry mouth
symptoms with low androgens and
dry eyes with low estrogens. Exogenous DHEA was
preferentially transformed into androgens rather than into estrogens" -
See
DHEA at Amazon.com.
Glycemic
load, glycemic index and breast cancer risk in a prospective cohort of Swedish
women - Int J Cancer. 2009 Feb 3 - "In analyses
stratified by estrogen receptor (ER) and progesterone receptor (PR) status of
the breast tumors, we observed statistically significant positive associations
of carbohydrate intake, glycemic index and
glycemic load with risk of ER+/PR- breast cancer;
the multivariate relative risks comparing extreme quintiles were 1.34 [95%
confidence interval (CI) = 0.93-1.94; p for trend = 0.04] for carbohydrate
intake, 1.44 (95% CI = 1.06-1.97; p for trend = 0.01) for glycemic index and
1.81 (95% CI = 1.29-2.53; p for trend = 0.0008) for glycemic load. No
associations were observed for ER+/PR+ or ER-/PR- breast tumors. These findings
suggest that a high carbohydrate intake and diets with high glycemic index and
glycemic load may increase the risk of developing ER+/PR- breast cancer"
Efficacy and
safety of therapy with metformin plus pioglitazone in the treatment of patients
with type 2 diabetes: a double-blind, placebo-controlled, clinical trial -
Curr Med Res Opin. 2009 Mar 23 - "Mean
HbA(1c) was reduced by 0.67% in patients receiving
pioglitazone plus metformin versus an increase
of 0.25% in those receiving metformin alone (p < 0.0001). After 8 weeks'
treatment and until the end of the study, HbA(1c) was significantly lower with
pioglitazone plus
metformin and more patients in this group achieved an HbA(1c) < 6.5% (38.6% vs.
8.1%; p < 0.0001). FBG was also reduced by a significantly greater amount in
patients receiving pioglitazone plus metformin compared with metformin
monotherapy (-20.5 vs. 1.9 mg/dl; p < 0.0001). Combination therapy was
associated with significantly increased HDL-cholesterol, total cholesterol, and
adiponectin, and significantly decreased
levels of fasting insulin, free fatty acids, and homeostasis model assessment
insulin resistance (HOMA-R) compared with metformin monotherapy" - See
pioglitazone at
OffshoreRx1.com.
Health Focus (Psoriasis):
Popular Supplements:
Alternative News:
-
Indigo Ointment Relieves Psoriasis - WebMD, 11/17/08
-
Seeking Natural Psoriasis Relief? - Dr. Weil, 11/16/07
-
Green Tea Holds Promise As New Treatment For Inflammatory Skin Diseases
- Science Daily, 8/7/07 - "Green tea could hold
promise as a new treatment for skin disorders such as psoriasis and dandruff
... Animal models treated with green tea also showed reduced levels of
proliferating cell nuclear antigen, a gene expressed when skin cells
multiply. In psoriasis, the gene is over-expressed and speeds production of
skin cells"
-
Folic acid in general medicine and dermatology - J Dermatolog Treat.
2007;18(3):138-46 - "Folic acid supplementation
appears as a reasonable therapeutic option in patients affected by chronic
inflammatory skin diseases, such as moderate to severe psoriasis; in
particular, those with concomitant hyperhomocysteinemia, low plasma folate
and additional cardiovascular risk factor"
-
Shining a Light on the Health Benefits of Vitamin D - New York Times,
1/28/03 -
"His proudest accomplishments, he says, include
discoveries that show how activated vitamin D
can be used to treat
osteoporosis,
kidney failure and psoriasis"
News & Research:
-
FDA Issues Public Health Advisory About Psoriasis Drug Raptiva Tied to Brain
Infection - WebMD, 2/19/09
-
Psoriasis Ointment Gets FDA Approval - WebMD, 2/3/09
-
Patients With Severe Psoriasis Need Evaluation Of Heart Disease Risk -
Science Daily, 12/18/08
-
Fat Hormone Linked to Psoriasis - WebMD, 12/15/08 -
"People with psoriasis may face a higher risk of
obesity, metabolic syndrome, and other heart disease risk factors thanks to
high levels of the so-called fat hormone leptin"
-
FDA Panel OKs Enbrel for Kids' Psoriasis - WebMD, 6/19/08
-
FDA Panel Backs New Psoriasis Drug - Science Daily, 6/17/08
-
New Psoriasis Drug Passes Hurdle - WebMD, 4/17/08
-
Thiazolidinediones May Act Against Psoriasis - Medscape, 3/26/08 -
"The adjusted odds ratio for a first time diagnosis
of psoriasis in current users of five or more prescriptions for
thiazolidinediones was 0.33, as compared to no use. The adjusted odds ratio
for metformin was 0.77" - See pioglitazone at
OffshoreRx1.com.
-
Severe Psoriasis Associated With Increased Risk Of Death - Science
Daily, 12/17/07
-
Smoking Increases Risk Of Psoriasis, Study Shows - Science Daily,
10/29/07
-
Drug
Effective In Treatment Of Heavy Psoriasis Patients - Science Daily,
8/3/07
-
Efalizumab Effective in Treatment of Heavy Psoriasis Patients - Doctor's
Guide, 8/2/07
-
Long-term Etanercept Treatment Reduces Psoriasis Severity Without Increased
Adverse Events - Science Daily, 6/18/07
-
Psoriasis Linked To Diabetes And Serious Cardiovascular Condition -
Science Daily, 4/18/07
-
New Treatment for Psoriasis Is Highly Effective - Doctor's Guide, 2/8/07
-
Psoriasis Patients Show Significant Improvement in Symptoms with Abbott's
Humira(R) in New Phase 3 Study - Doctor's Guide, 2/2/07
-
Stiefel Laboratories Receives FDA Approval of Olux-E (Clobetasol Propionate)
Foam, 0.05% for Treatment of Psoriasis and Eczema - Doctor's Guide,
1/23/07
-
Psoriasis Patients Improve with Infliximab (Remicade) Treatment -
Doctor's Guide, 10/11/06
-
Adalimumab Was Statistically Superior to Methotrexate in Patients With
Psoriasis - Doctor's Guide, 10/6/06
-
FDA Approves Remicade(R) (Infliximab) for Treatment of Chronic Severe Plaque
Psoriasis - Doctor's Guide, 9/27/06
-
Treating Itch in Psoriasis - Medscape, 8/24/06
-
Study Compares Treatments for Chronic Plaque Psoriasis - Doctor's Guide,
7/21/06
-
Taclonex New Dual-Action Topical Therapy for Plaque Psoriasis Now Available
for Prescription - Doctor's Guide, 4/3/06
-
Efalizumab (Raptiva) Appears Safe for Up to 3 years of Psoriasis Therapy
- Doctor's Guide, 3/9/06
-
Low-Dose Regimens of Acitretin (Soriatine) Effective in the Treatment of
Moderate-to-Severe Plaque-Type Psoriasis - Doctor's Guide, 3/7/06
-
Phase 3 Data Show Rapid and Significant Improvement and Long-Term Response
to Remicade (infliximab) in the Treatment of Moderate to Severe Psoriasis
- Doctor's Guide, 3/3/06
-
New Skin Cream Approved for Psoriasis - WebMD, 1/13/06
-
FDA Approves Taclonex (Calcipotriene/Betamethasone Dipropionate), Once Daily
Therapy for Treatment of Psoriasis - Doctor's Guide, 1/10/06
-
Smoking May Make Psoriasis Worse - WebMD, 12/19/05
-
Etanercept May Be Helpful for Treatment of Psoriasis - Medscape,
12/15/05
-
New Safety Information for Amevive (alefacept) - Doctor's Guide,
11/10/05
-
Psoriasis
Sufferers No Longer Held Hostage by Disease - ABC News, 10/28/05
-
Galderma Receives FDA Approval for Clobex (Clobetasol Propionate) Spray for
Moderate-to-Severe Plaque Psoriasis - Doctor's Guide, 10/28/05
-
Study Shows Infliximab (Remicade) Improves Psoriasis Symptoms - Doctor's
Guide, 10/14/05
-
Remicade 'Highly Effective' for Psoriasis - WebMD, 10/13/05
-
Remicade (Infliximab) Appears Effective for Treatment of Psoriatic
Arthritis-Related Conditions - Doctor's Guide, 2/23/05
- Biologic Drugs
Treat Tough Psoriasis Cases - WebMD, 2/22/05
-
Second Course of Alefacept Often Successful for Plaque Psoriasis Even if
First Course Fails - Doctor's Guide, 2/21/05
-
Sustained Improvement Seen With Adalimumab Therapy for Psoriasis -
Doctor's Guide, 2/21/05
-
Adalimumab Effective in Clearing Patients of Psoriatic Arthritis After 24
Weeks of Therapy - Doctor's Guide, 2/21/05
-
Humira (Adalimumab) Appears to Provide Improvement in Disease Activity,
Quality of Life for Patients with Psoriasis - Doctor's Guide, 2/21/05
- Potential Target
for Treating Psoriasis Found - WebMD, 12/13/04
- Simplified Psoriasis
Area Severity Index (SPASI) - Medscape, 12/6/04
- Cost of Psoriasis
Therapy: Considerations for Therapy Selections - Medscape, 11/29/04
-
Possible New Cure For Psoriasis - Science Daily, 8/17/04
-
Possible New Cure for Psoriasis Found - Doctor's Guide, 8/16/04
-
Psoriasis Patients Respond Similarly to Etanercept Therapy, Regardless of
Treatment History - Doctor's Guide, 8/5/04
-
Adalimumab Shows Extraordinary Results In Moderate-To-Severe Plaque
Psoriasis - Doctor's Guide, 8/4/04
- Humira
Improves Life With Psoriasis - WebMD, 8/4/04
-
Alefacept Proves Safe and Effective in Plaque Psoriasis Over 16 Weeks of
Therapy - Doctor's Guide, 8/3/04
-
Efalizumab Provides Sustained Efficacy in Moderate-to-Severe Psoriasis Over
30 Months - Doctor's Guide, 8/3/04
-
Using Clobetasol Foam And Calcipotriene Ointment May Enhance Efficacy In
Mild-To-Moderate Psoriasis - Doctor's Guide, 8/3/04
-
Tazarotene Appears Effective Treatment in Psoriasis of Knees, Elbows, and
Scalp - Doctor's Guide, 8/3/04
- New Treatments
Ease Eczema, Psoriasis - WebMD, 7/29/04
- Topical Paricalcitol
Helpful for Plaque Psoriasis - Medscape, 7/23/04
-
Chronic Plaque Psoriasis Responds Well To Calcitriol Ointment in Large
Studies - Clinical Psychiatry News, 5/04
-
FDA Approves Biologic Drug, Enbrel (Etanercept), for Psoriasis -
Doctor's Guide, 5/3/04
-
Recent Study Shows Treatment-Free Periods with New Biologic, Alefacept for
Psoriasis - Doctor's Guide, 3/31/04
-
Even a 'Small' Amount of Psoriasis Can Negatively Impact Daily Life -
Doctor's Guide, 3/29/04
-
Hype and Hope of Psoriasis Biologics Examined - Clinical Psychiatry
News, 3/04
-
Oral Tazarotene Appears Tolerable, Safe and Effective in Long-term Treatment
of Moderate to Severe Plaque Psoriasis - Doctor's Guide, 2/10/04
-
Infliximab Might Improve Quality-of-Life in Patients With Severe Plaque
Psoriasis - Doctor's Guide, 2/10/04
-
Twice-Weekly Etanercept Highly Effective Against Chronic Plaque Psoriasis
- Doctor's Guide, 2/10/04
- Psoriasis Takes
Toll on Mind as Well as Skin - WebMD, 2/9/04
-
Adalimumab Safe, Has Dose-Related Efficacy For Psoriasis - Doctor's
Guide, 2/9/04
-
Combination Of Infliximab And Hydroxyurea Offers Potential Treatment Of
Severe Psoriasis And Psoriatic Arthritis - Doctor's Guide, 1/19/04
- New Psoriasis
Treatments Look Good - WebMD, 12/16/03
-
Alefacept Therapy May Result In Prolonged Psoriasis Remission Through
Reduction Of T-Cell Subsets - Doctor's Guide, 12/16/03
- Etanercept
Monotherapy Helpful in Psoriasis - Medscape, 12/15/03
-
Etanercept may be a Feasible Treatment for Plaque Psoriasis - Doctor's
Guide, 11/21/03
-
Efalizumab Improves Symptoms in Some Patients with Plaque Psoriasis -
Doctor's Guide, 11/21/03
- New Psoriasis
Treatments Work - WebMD, 11/19/03
- Psoriasis May
Increase Cancer Risk - WebMD, 11/17/03
-
Large Study Links Psoriasis and Depressive Symptoms - Doctor's Guide,
11/10/03
-
New psoriasis drug wins FDA approval to use by adults - USA Today,
10/28/03
-
Etanercept (Enbrel) Effective, Safe as Psoriasis Monotherapy, Even in High
Doses - Doctor's Guide, 10/28/03
-
Leflunomide May Be Effective in Treatment of Psoriatic Arthritis and
Psoriasis - Doctor's Guide, 10/27/03
-
Daivobet Effective in Treating Severe Psoriasis - Doctor's Guide,
10/21/03
-
Renal Function Not Always Severely Affected by Long-term Cyclosporin
Treatment for Psoriasis - Doctor's Guide, 10/21/03
-
FDA Advisory Committee Unanimously Recommends Approval For Raptiva
(Efalizumab) As Potential Treatment For Moderate-To-Severe Plaque Psoriasis
- Doctor's Guide, 9/10/03
-
Methotrexate and Cyclosporine Show Similar Efficacy, Tolerability for
Psoriasis - Doctor's Guide, 8/14/03
- Psoriasis
Treatments Face Off - WebMD, 8/13/03
- Raptiva Works
for Psoriasis Treatment - WebMD, 8/5/03
-
Treatments Available for Arthritis in Psoriatic Patients - Doctor's
Guide, 8/1/03
-
Raptiva (Efalizumab) Promising As Long-Term Treatment For Moderate-To-Severe
Plaque Psoriasis - Doctor's Guide, 7/28/03
-
No Need for Concern about Malignancies with Etanercept Treatment -
Doctor's Guide, 6/24/03
-
Alefacept Effective in Patients with Difficult-to-Treat Psoriasis -
Doctor's Guide, 6/24/03
-
Enbrel (Etanercept) Provided Rapid, Significant Relief For Psoriasis
Patients In Second Pivotal Study - Doctor's Guide, 6/23/03
-
Onercept (r-hTBP-1) Promising Treatment For Psoriasis, Psoriatic Arthritis
- Doctor's Guide, 6/23/03
- New Psoriasis
Treatment [Amevive] Offers Hope - WebMD, 6/16/03
-
AMA Biologic Treatments: The Future of Psoriasis Therapy? - Doctor's
Guide, 6/11/03
- Psoriasis
Treatments Entering New Era - WebMD, 6/5/03
-
Topiramate Clears Psoriasis in Mood Disorder Patients - Clinical
Psychiatry News, 5/03
-
Soriatane (Acitretin) Label Update Clarifies Use In Severe Psoriasis -
Doctor's Guide, 5/8/03
-
Repeated Courses Of Alefacept Well Tolerated And Effective In Chronic Plaque
Psoriasis - Doctor's Guide, 4/10/03
-
Topical Cyclosporin A Conjugate Agent Shows Modest Efficacy for Plaque
Psoriasis - Doctor's Guide, 3/26/03
-
Infliximab Demonstrates Safety and Efficacy for Treatment of Psoriasis -
Doctor's Guide, 3/25/03
-
Topical Therapy with Oral Systemic Cyclosporin Solution Effective in
Psoriatic Nails - Doctor's Guide, 3/24/03
-
Oral Pimecrolimus Effective In Treating Psoriasis - Doctor's Guide,
3/24/03
-
Efalizumab Demonstrates Efficacy and Tolerability Long-Term in Psoriasis
- Doctor's Guide, 3/24/03
-
Alefacept (Amevive) Biologic Therapy As Effective In Severe Psoriasis As In
Milder Cases - Doctor's Guide, 3/24/03
-
Competition Expected For New, Improved Psoriasis Drugs - Intelihealth,
3/24/03
-
Etanercept an Effective Monotherapy for Psoriasis - Doctor's Guide,
3/13/03
-
Calcitriol Better Than Calcipotriol For Psoriasis In Sensitive Areas -
Doctor's Guide, 3/6/03
-
Methotrexate/Calcipotriol Combination Decrease Side-Effects in Psoriasis
Patients - Doctor's Guide, 2/28/03
-
New Systemic Psoriasis Therapy - Physician's Weekly, 2/17/03
-
Alefacept Improves Quality Of Life For Patients With Psoriasis -
Doctor's Guide, 2/10/03
-
FDA Approves Amevive (Alefacept) For Treatment of Psoriasis - Doctor's
Guide, 1/31/03
-
Calcipotriene/ Betamethasone Dipropionate Combo Acts Faster And More
Effectively In Psoriasis Vulgaris Therapy - Doctor's Guide, 1/24/03
-
New Cyclosporine Protocol Effective Against Severe Psoriasis - Doctor's
Guide, 1/10/03
-
FDA Expands Approval For Olux (Clobetasol Propionate) Foam For Psoriasis Of
Non-Scalp Regions - Doctor's Guide, 12/23/02
-
Dithranol For Psoriasis More Beneficial Once Daily - Doctor's Guide,
12/20/02
-
Optimal Narrowband Ultraviolet B Light Phototherapy for Psoriasis -
Doctor's Guide, 11/14/02
-
Increased Dose Of Calcipotriol May Improve Response In Some Psoriasis
Patients - Doctor's Guide, 9/23/02
-
Calcipotriol Ointment May Improve Results Of Phototherapy For Psoriasis
- Doctor's Guide, 9/16/02
-
Calcipotriol/Fumaric Acid Ester Combo Quicker, More Effective Treatment for
Severe Plaque Psoriasis - Doctor's Guide, 8/28/02
-
Tacalcitol Ointment Controls Chronic Plaque Psoriasis - Doctor's Guide,
8/6/02
-
Penile, Scrotal Cancer Still Linked To Psoralen Plus Ultraviolet-A Psoriasis
Treatment - Doctor's Guide, 7/23/02
-
Early-Onset Psoriasis That Runs In Families Genetically Similar To Sporadic
Psoriasis - Doctor's Guide, 7/22/02
-
Corticosteroid Foam Effectively Treats Non-Scalp Psoriasis - Doctor's
Guide, 7/12/02
-
Psoriatic Skin Lesions Improve with Infliximab - Doctor's Guide, 7/4/02
-
Calcitriol is Better than Calcipotriol in Psoriasis of Sensitive Areas -
Doctor's Guide, 7/4/02
-
Tazarotene Gel Improves Fingernail Psoriasis - Doctor's Guide, 7/1/02
- Laser Treatment
Promising in Vitiligo, Psoriasis - Medscape, 6/11/02
-
FDA Advisory Committee Recommends Approval of Biogen's Amevive (Alefacept)
- Doctor's Guide, 5/23/02
-
Anti-E-Selectin For Psoriasis Ineffective - Doctor's Guide, 5/23/02
-
Biological Therapies Target T-Cell Pathology Of Psoriasis - Doctor's
Guide, 2/26/02
-
Commercial Tanning Beds Provide Effective and Accessible Light Therapy for
Psoriasis - Doctor's Guide, 2/25/02
- Arthritis Drugs
Provide Psoriasis Relief - WebMD, 2/22/02
-
Enbrel (Etanercept) Effective In Treating Psoriasis - Doctor's Guide,
2/22/02
-
Remicade (Infliximab) Effective In Treating Moderate To Severe Psoriasis
- Doctor's Guide, 2/22/02
- FDA Approves Rheumatoid
Arthritis Drug, Enbrel (Etanercept), For Treatment Of Psoriatic Arthritis
- Doctor's Guide, 1/16/02
- Enbrel (Etanercept)
Effective for Psoriatic Arthritis - Doctor's Guide, 11/12/01
-
Increased Skin Cancer Risk With Combo Therapy For Severe Psoriasis -
Doctor's Guide, 9/28/01
- Efalizumab Promising In
Treatment Of Moderate-To-Severe Plaque Psoriasis - Doctor's Guide,
8/3/01
- Second Course Of Alefacept
Provides Continued Response Against Chronic Plaque Psoriasis - Doctor's
Guide, 8/2/01
- Efalizumab Improves
Quality Of Life In Moderate To Severe Plaque Psoriasis - Doctor's Guide,
7/30/01
- New Hope for the
Heartbreak of Psoriasis - WebMD, 7/25/01
- Remicade (Infliximab)
Provides Significant, Sustained Benefit in Psoriasis - Doctor's Guide,
6/21/01
- New Treatments on
the Horizon for Psoriasis - Doctor's Guide, 6/25/01
-
Study Links Psoriasis, Cancer Risks - Intelihealth, 6/15/01
-
Severe psoriasis linked to lymphoma, skin cancer - USA Today, 6/14/01
- Enbrel (Etanercept)
Effective In Patients With Psoriatic Arthritis And Psoriasis - Doctor's
Guide, 6/14/01
- Study: Arthritis
Drug [Remicade] Shows Early Promise in Relieving Psoriasis Symptoms -
WebMD, 6/8/01
- FDA Approves Trexall
(Methotrexate) For Neoplastic Disease, Psoriasis And Rheumatoid Arthritis
- Doctor's Guide, 3/22/01
- New Hope for the
Heartbreak of Psoriasis? - WebMD, 3/19/01 -
"new options to treat severe psoriasis are on the
horizon. These include improved creams, new drugs, and even laser therapy.
One of these new drugs, which will be marketed by its manufacturer,
Genentech Inc., as Xanelim, is showing great promise in early research ...
If future studies continue to go as planned, the company hopes to submit the
drug to the FDA for approval in the late fall"
- Positive Results In
Retreatment With Amevive (Alefacept) For Chronic Plaque Psoriasis -
Doctor's Guide, 3/5/01
- New Combinations Offer
Positive Results For Psoriasis - Doctor's Guide, 3/5/01
- Recent Innovations Improve
Psoriasis Treatment - Doctor's Guide, 3/4/01
- Short-course, Flat-dose
Neoral (Cyclospine A) Safe, Effective For Psoriasis - Doctor's Guide,
10/16/00
- Laser Therapy May Benefit
Patients With Psoriasis And Vitiligo - Doctor's Guide, 8/3/00
- For Psoriasis,
Laser Treatment Looks Promising - WebMD, 5/25/00
- Women With Severe
Psoriasis Not Always Treated Effectively, Study Shows - Doctor's Guide,
4/3/00
- Clobetasol Foam Gives
Better Results Than Clobetasol Solution For Scalp Psoriasis - Doctor's
Guide, 3/13/00
- Betamethasone Valerate
Foam Effective In Some Psoriasis Patients - Doctor's Guide, 2/9/00
- Amevive Provides
Therapeutic Effect For Psoriasis - Doctor's Guide, 12/3/99
- Human Antibody Found
Promising For Psoriasis Treatment - Doctor's Guide, 12/1/99
- Neoral Study Visually
Confirms Efficacy In Severe, Recalcitrant, Plaque Psoriasis - Doctor's
Guide, 3/22/99
- New Psoriasis Treatment
Clears Lesions, Eases Pain - Doctor's Guide, 2/18/98
- New Laser Treatment For
Psoriasis - Doctor's Guide, 11/21/97
- Advances In Psoriasis
Treatment Offer Hope To Millions - Doctor's Guide, 10/30/97
- New Retinoid Gel Offers
Topical Therapy of Psoriasis - Doctor's Guide, 8/27/97
- Psoriasis Update: New
Treatment, But Still No Cure - Doctor's Guide, 8/1/97
- Tazarotene Is First New
Generation Retinoid For Treating Plaque Psoriasis - Doctor's Guide,
6/19/97
- Pandel Cream on the Market
for Psoriasis and Dermatitis - Doctor's Guide, 3/21/97
No pathinfo
|
|